Media Room
Second Quarter 2025
Second quarter 2025 results were reviewed by management during a live audio webcast with the financial community on July 31, 2025. The presentation was followed by a Q&A session.
Press releases
August 14, 2025
Press Release: Sanofi’s rilzabrutinib earns orphan designation in the EU for IgG4-related disease
August 6, 2025
Press Release: Sanofi completes the acquisition of Vigil Neuroscience, Inc.
July 31, 2025
Press release: Online availability of Sanofi’s half-year financial report for 2025
Contact Our Media Team
You are a journalist and have a question about Sanofi, please contact the Global Media relations team. Please note the contact details are only for journalists.
Publications
Half year 2025 financial report XBRL package
Half Year 2025 Financial Report
Sustainability Statement 2024 (ESG Report)
Registration Document 2024 (in French)